New drug tested to help control serious lung disease
NCT ID NCT06099652
Summary
This study tested whether an investigational drug called 611 could help control moderate-to-severe chronic obstructive pulmonary disease (COPD) in Chinese adults. 142 participants who were already on standard COPD medications received either 611 or a placebo for 16 weeks. Researchers measured changes in lung function, symptom scores, and flare-ups to see if 611 was effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY DISEASE, CHRONIC OBSTRUCTIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
China-Japan Friendship Hospital
Beijing, Beijing Municipality, 100029, China
-
Shenzhen People's Hospital
Shenzhen, Guangdong, 518020, China
-
Zhongshan Hospital affiliated to Fudan University
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.